.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Fuji
AstraZeneca
Medtronic
Colorcon
Accenture
Farmers Insurance
Federal Trade Commission
Dow

Generated: January 20, 2018

DrugPatentWatch Database Preview

Patents Expiring in December 2021

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mylan Speciality LpACCUNEBalbuterol sulfateSOLUTION;INHALATION020949-002Apr 30, 2001ANRXYesYes➤ Subscribe➤ SubscribeINDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE)
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-002Oct 19, 2010RXYesYes➤ Subscribe➤ SubscribeYY
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-003Nov 20, 2015RXYesNo➤ Subscribe➤ SubscribeYY
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-001Oct 19, 2010RXYesNo➤ Subscribe➤ SubscribeYY
Mylan Speciality LpDUONEBalbuterol sulfate; ipratropium bromideSOLUTION;INHALATION020950-001Mar 21, 2001DISCNYesNo➤ Subscribe➤ SubscribeTREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD IN PATIENTS REQUIRING MORE THAN ONE BRONCHO DILATOR
Mylan Speciality LpACCUNEBalbuterol sulfateSOLUTION;INHALATION020949-001Apr 30, 2001ANRXYesYes➤ Subscribe➤ SubscribeINDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE)
Pacira Pharms IncEXPARELbupivacaineINJECTABLE, LIPOSOMAL;INJECTION022496-002Oct 28, 2011RXYesYes➤ Subscribe➤ SubscribeY
Pacira Pharms IncEXPARELbupivacaineINJECTABLE, LIPOSOMAL;INJECTION022496-001Oct 28, 2011RXYesYes➤ Subscribe➤ SubscribeY
Bayer HlthcareCIPRO XRciprofloxacin; ciprofloxacin hydrochlorideTABLET, EXTENDED RELEASE;ORAL021473-002Aug 28, 2003DISCNNoNo➤ Subscribe➤ SubscribeY
Bayer HlthcareCIPRO XRciprofloxacin; ciprofloxacin hydrochlorideTABLET, EXTENDED RELEASE;ORAL021473-002Aug 28, 2003DISCNNoNo➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Queensland Health
US Army
Teva
Colorcon
Covington
Boehringer Ingelheim
AstraZeneca
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot